Acupressure for Cough in Lung Cancer Survivors
Official title: Acupressure for Cough in Lung Cancer Survivors: A Randomized Controlled Trial
Run by The University of Hong Kong · NCT07315672 · Data updated 2026-11-12
This trial tests whether self-administered acupressure can lessen cough and related symptoms in people who have survived lung cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 2 sites (Shenzhen, Guangdong and 1 other locations) |
| Status | Recruiting |
| Started | March 9, 2026 |
| Main results expected | December 2026 |
| Study ends | February 2027 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT07315672 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with lung cancer (any stage/type) who have a cough rated 3 or higher and can perform self-acupressure.
✕Probably not a fit
Individuals who do not experience symptom relief or who have conditions preventing adherence to the protocol may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial compares an eight-week self-administered acupressure program to receiving an educational booklet for lung cancer survivors with cough. Participants will keep a diary of their acupressure practice and symptoms and be assessed at baseline, during early intervention, after the eight-week period, and eight weeks later. The study aims to see if acupressure can reduce cough and the related symptom cluster of dyspnea and fatigue, and improve overall symptom burden, daily functioning, and quality of life. Eligible participants are adults with a lung cancer diagnosis who have a cough of moderate or greater severity and can perform acupressure themselves, with literacy in Chinese and ability to communicate in Cantonese or Mandarin. The study is conducted at centers affiliated with The University of Hong Kong and its partners in Hong Kong and Shenzhen.
Why it matters
Potential benefit: If successful, participants may experience relief from cough and related symptoms and a better quality of life.
How similar studies have gone: Prior research in symptom management for cancer patients has shown benefits from non-pharmacologic approaches like acupressure in certain symptom clusters; this trial tests its applicability to lung cancer cough specifically.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * be at least 18 years of age; * have a diagnosis of LC at any stage and of any pathological type; * have a cough symptom rating ≥3 on a 0 to 10 numeric rating scale within 7 days preceding enrollment; * can perform acupressure independently in daily activities; * be able to read Chinese and communicate in Cantonese or Mandarin; * be able to provide informed consent. Exclusion Criteria: * have unstable chronic diseases other than LC; * have received acupressure or acupuncture within the three months preceding study enrollment; * have serious illnesses or other conditions that prevent the participants from following the intervention protocols; * have a life expectancy of less than 3 months; * Be currently participating in other research programs that may affect the outcomes under investigation.
Where it's running
-
University of Hong Kong-Shenzhen Hospital
Shenzhen, Guangdong, China Recruiting -
Queen Mary Hospital
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Mengyao Cao
- Email: u3590805@connect.hku.hk
- Phone: +852-96733602
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Boosting lung cancer screening for patients seen in the emergency department
This project will test whether giving eligible emergency department patients a facilitated referral plus text reminders helps more people get lung cancer screening.
-
Acupressure to Ease Pain During ESWL for Kidney Stones
This study tests whether applying acupressure to specific points before ESWL can reduce pain and improve comfort for adults with kidney or proximal ureteral stones.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
AI-Personalized Discharge Education After Lung Cancer Surgery
This study tests whether an AI-generated, personalized discharge guide helps patients recover better after lung cancer surgery compared with standard discharge education.
-
Next Generation Delivery System (NGDS) for SBRT in thorax and upper abdomen
A study tests a new machine to deliver SBRT more quickly and comfortably for adults with thoracic or upper abdominal cancers.
-
Low-Intensity Endurance Exercise to Help Lung Cancer-Related Fatigue
This trial tests whether light, regular endurance exercise can help reduce fatigue and improve quality of life for people with lung cancer in addition to their usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.